biomarker

  • The third annual Regulatory Science to Advance Precision Medicine Forum was held on 25 September 2019at the PhRMA Foundation in Washington, D.C.With over 40 attendees from all areas of research and regulatory arenas in attendance, the Forum included participants from across academia, industry, government agencies, and foundations. The working group decided to continue on the theme of Digital Health, which was the focus for the second annual forum in 2018. In the context of digital health, the2019 Forum particularly focused on the opportunities and challenges to transform Real World Data (RWD) into Real World Evidence (RWE). The Forum identified some of the regulatory science opportunities and challenges for improving and utilizing digital measures as RWE to advance precision medicine. The breakout sessions focused on regulatory science needs and priorities for: 1) contributed data from biosensors and, 2) routinely collected data from the EMR and related administrative data.

    Document
    Publication Date
  • Poster

    Novel Integrative Markers to Define Human Disease

    University Of Massachusetts Med Sch Worcester
  • Consortium News
    KL2 Scholar Leads UCLA Team that Finds New Target for Diagnosing and Treating Lung Cancer